These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 6113526

  • 1. DPI, a supposed selective agonist of inhibitory dopamine receptors, strongly increases rat diuresis through alpha-adrenergic receptor activation.
    Baggio G, Ferrari F.
    Life Sci; 1981 Mar 30; 28(13):1449-56. PubMed ID: 6113526
    [No Abstract] [Full Text] [Related]

  • 2. Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an alpha 2-adrenergic mechanism.
    van Oene JC, Houwing HA, Horn AS.
    Eur J Pharmacol; 1982 Jun 16; 81(1):75-87. PubMed ID: 6126370
    [Abstract] [Full Text] [Related]

  • 3. Effects of DPI (2-(3,4-dihydroxyphenylimino)-imidazolidine) on prejunctional alpha-adrenoceptors and prejunctional dopamine receptors in the rabbit ear artery.
    Medgett IC.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun 16; 323(2):141-4. PubMed ID: 6136918
    [Abstract] [Full Text] [Related]

  • 4. Agonistic actions of DPI (2-(3,4-dihydroxyphenylimino)-imidazolidine) on alpha-adrenoceptors and dopamine receptors.
    Woodman OL, Medgett IC, Lang WJ, Rand MJ.
    Eur J Pharmacol; 1981 Oct 15; 75(1):11-9. PubMed ID: 6119208
    [Abstract] [Full Text] [Related]

  • 5. Antagonist properties of phentolamine at both presynaptic alpha 2-adrenoceptors and presynaptic dopamine receptors using field stimulated right cat atria.
    Koons JC, Flynn JR, Long JP.
    Eur J Pharmacol; 1983 Apr 08; 88(4):311-7. PubMed ID: 6305673
    [Abstract] [Full Text] [Related]

  • 6. Phentolamine inhibition of rat seminal vesicle response to dopamine-mimetic drugs: alpha-adrenoceptor implication or lack of specificity?
    Castelli M, Genedani S.
    J Pharm Pharmacol; 1982 May 08; 34(5):331-3. PubMed ID: 6123575
    [No Abstract] [Full Text] [Related]

  • 7. Prejunctional inhibitory alpha-adrenoceptors and dopaminoceptors of the rat vas deferens and the guinea-pig ileum in vitro.
    Tayo FM.
    Eur J Pharmacol; 1979 Sep 15; 58(2):189-95. PubMed ID: 227701
    [No Abstract] [Full Text] [Related]

  • 8. (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI) and its action at noradrenergic and dopaminergic receptors in the nucleus accumbens of rats: mesolimbic catecholamine receptors and hyperactivity.
    Cools AR, Oosterloo SK.
    J Neural Transm Suppl; 1983 Sep 15; 18():181-8. PubMed ID: 6308148
    [Abstract] [Full Text] [Related]

  • 9. Presence of a particular subpopulation of dopamine receptors within the septal nuclei: a behavioural study on cats.
    Megens AA, Cools AR.
    Eur J Pharmacol; 1981 May 08; 71(2-3):247-58. PubMed ID: 6265235
    [Abstract] [Full Text] [Related]

  • 10. Alpha-adrenoceptor and dopamine receptor antagonists do not block the slow inhibitory postsynaptic potential in sympathetic ganglia.
    Cole AE, Shinnick-Gallagher P.
    Brain Res; 1980 Apr 07; 187(1):226-30. PubMed ID: 6244069
    [No Abstract] [Full Text] [Related]

  • 11. Interaction between the inhibitory action of acetylcholine and the alpha-adrenoceptor autoinhibitory feedback system on release of [3H]-noradrenaline from rat atria and rabbit ear artery.
    Loiacono RE, Rand MJ, Story DF.
    Br J Pharmacol; 1985 Mar 07; 84(3):697-705. PubMed ID: 2859064
    [Abstract] [Full Text] [Related]

  • 12. Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice.
    Costall B, Lim SK, Naylor RJ.
    Eur J Pharmacol; 1981 Jul 17; 73(2-3):175-88. PubMed ID: 6118281
    [Abstract] [Full Text] [Related]

  • 13. The pharmacological characterization of 3,4-dihydroxyphenylimino-2-imidazolidine (DPI) as a potent mixed alpha 1/alpha 2-adrenoceptor agonist rather than as a dopamine receptor agonist.
    van Oene JC, Horn AS.
    J Pharm Pharmacol; 1985 Nov 17; 37(11):844-7. PubMed ID: 2867175
    [No Abstract] [Full Text] [Related]

  • 14. Dopamine and alpha adrenoceptor agonists inhibit neurotransmission in the cat spleen through different presynaptic receptors.
    Dubocovich ML, Langer SZ.
    J Pharmacol Exp Ther; 1980 Jan 17; 212(1):144-52. PubMed ID: 6101339
    [No Abstract] [Full Text] [Related]

  • 15. Inhibitory alpha-2 adrenoceptors in human adipose tissue.
    Lafontan M, Berlan M.
    Int J Obes; 1981 Jan 17; 5(6):651-7. PubMed ID: 6119296
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices.
    Misu Y, Goshima Y, Ueda H, Kubo T.
    J Pharmacol Exp Ther; 1985 Dec 17; 235(3):771-7. PubMed ID: 3001276
    [Abstract] [Full Text] [Related]

  • 18. Presynaptic alpha 2- and dopamine-receptor-mediated inhibitory mechanisms and dopamine nerve terminals in the rat hypothalamus.
    Ueda H, Goshima Y, Misu Y.
    Neurosci Lett; 1983 Sep 30; 40(2):157-62. PubMed ID: 6314206
    [Abstract] [Full Text] [Related]

  • 19. Changes in dopamine and DOPAC following systemic administration of apomorphine and 3,4-dihydroxyphenylamino-2-imidazoline (DPI) in rats.
    Springer J, Hannigan JH, Isaacson RL.
    Brain Res; 1981 Sep 07; 220(1):226-30. PubMed ID: 7272755
    [Abstract] [Full Text] [Related]

  • 20. Receptor interactions of imidazolines. I. Affinity and efficacy for alpha adrenergic receptors in rat aorta.
    Ruffolo RR, Rosing EL, Waddell JE.
    J Pharmacol Exp Ther; 1979 Jun 07; 209(3):429-36. PubMed ID: 35606
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.